Doloten

Quick links to important sections

Doloten

Treatment option: Pain

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Doloten

Quick Facts

Property Description
Active ingredient Acetaminophen, Tramadol Hydrochloride
Form Oral tablet (fixed-dose combination)
Pharmacological class Combination Analgesic, Centrally Acting Analgesic
General purpose Relief of moderate to severe pain
Origin Synthetic

Identity, Classification, and Composition

Doloten is a synthetic, prescription-only combination analgesic classified as a Centrally Acting Analgesic designed for the management of moderate to severe pain. This pharmaceutical preparation is presented as an oral tablet and functions as a fixed-dose combination product, delivering its therapeutic effect through two distinct active agents simultaneously. The use of this specific combination is clinically recognized when pain relief from a non-opioid medicine alone proves insufficient. This positioning targets it toward patients requiring consistent, potent relief beyond over-the-counter options.

The drug's composition is defined by its two active ingredients: Acetaminophen (also known as Paracetamol) and Tramadol Hydrochloride. This formulation is characterized by the presence of both a non-opioid component (Acetaminophen) and a synthetic opioid component (Tramadol). The pharmacological classification of Acetaminophen is as a mild analgesic and antipyretic, while Tramadol acts primarily as an opioid agonist with additional properties. The simultaneous inclusion of these two substances is specifically formulated to achieve a synergistic effect, meaning their combined action targets pain using multiple physiological pathways to enhance overall effectiveness.

Regulatory References

  1. Tramadol Hydrochloride and Acetaminophen Tablets Label (DailyMed)

What side effects are possible with Doloten?

Possible Side Effects and Safety Information

Doloten (referred to by its active substance) is associated with risks common to opioids and unique concerns related to its dual action. Due to its potential for serious harm, regulatory bodies have issued strong warnings and restrictions on its use.


Serious and Clinically Significant Adverse Reactions

The most critical risk is life-threatening respiratory depression, which can be fatal. This risk is higher at treatment initiation, following a dose increase, and in patients with chronic pulmonary disease, older adults, or individuals who are ultra-rapid metabolizers. The drug is also subject to warnings regarding addiction, abuse, and misuse, which can lead to overdose and death. Long-term use during pregnancy can result in Neonatal Opioid Withdrawal Syndrome.

Other serious risks include Serotonin Syndrome, a potentially fatal condition when the drug is used with other serotonergic agents, and the risk of seizures or convulsions, which may occur even at recommended doses. Cases of severe allergic reactions, including anaphylaxis and serious skin reactions like Stevens-Johnson Syndrome, have also been reported.


Common Adverse Reactions

Adverse reactions reported at a frequency of Very Common (ge1/10) or Common (ge1/100 to <1/10) include gastrointestinal disorders such as nausea, constipation, and vomiting; nervous system effects like dizziness, headache, and somnolence (drowsiness); and other effects like hyperhidrosis (increased sweating) and fatigue.


Safety Restrictions and Contraindications

Doloten is contraindicated in several specific populations and conditions, including:

  • Children younger than 12 years of age.
  • Postoperative pain management in children younger than 18 years following tonsillectomy and/or adenoidectomy.
  • Patients with significant respiratory depression or acute/severe bronchial asthma in an unmonitored setting.
  • Patients taking Monoamine Oxidase Inhibitors (MAOIs) or within 14 days of stopping such treatment.

Caution is required when used in patients with a history of seizures, head injury, increased intracranial pressure, or severe hepatic or renal impairment. Breastfeeding is not recommended due to the risk of serious adverse reactions in the infant. Professional monitoring is essential, particularly at the start of therapy, to manage the risks of respiratory depression and CNS effects.

Overdose and Emergency Response

The official regulatory profile for Doloten overdose is defined by the specific, potentially life-threatening toxicities of its two components: the opioid (Tramadol) and the non-opioid (Acetaminophen). Immediate medical attention must be sought for any suspected overdose, regardless of the patient’s initial condition.

Manifestations from the opioid component may include severe sedation, pinpoint pupils (miosis), and disturbances of consciousness, escalating to convulsions/seizures and life-threatening respiratory depression. This can ultimately lead to respiratory arrest and cardiovascular collapse. Signs of the acetaminophen component’s toxicity can include initial symptoms like nausea, vomiting, pallor, and abdominal pain, but the primary concern is the potential for delayed, fatal hepatic failure which may progress to encephalopathy and is often not fully apparent until 12 to 48 hours after ingestion.

Management protocols documented in regulatory sources require addressing this dual toxicity. The use of the antidote Naloxone is noted for reversing respiratory depression from the opioid component, though its administration may increase the risk of seizures. N-acetylcysteine (NAC) is the specific antidote for acetaminophen toxicity. Supportive procedures officially described include re-establishing a patent airway, instituting assisted ventilation, and monitoring for signs of Serotonin Syndrome. Accidental ingestion by children carries a significant regulatory warning due to the high risk of fatal overdose.

Therapeutic Uses of Doloten

What Doloten Treats: Main Uses and Benefits

The combination of Acetaminophen and Tramadol is relevant in contexts marked by increased discomfort or tension. It is used in areas where short-term symptom management is appropriate, particularly when the patient requires additional symptomatic support. This medication is indicated for situations where existing symptomatic management is insufficient.


Managing Moderate to Severe Pain

This combination analgesic is commonly used across conditions marked by increased physiological stress related to moderate to severe pain. It is relevant for managing symptoms that interfere with daily comfort and is applied when symptoms create noticeable functional strain. The therapeutic benefit is offering symptomatic relief that contributes to easing the overall symptom load in situations where symptoms may intensify temporarily. It is also relevant in contexts involving heightened systemic burden where prior symptomatic support was limited.

Symptomatic Support for Acute and Episodic Scenarios

The medication is commonly used across conditions presenting with acute episodes or conditions involving episodic or fluctuating manifestations of discomfort. These contexts include postoperative discomfort and certain types of musculoskeletal pain, such as pain from osteoarthritis. The benefit is offering supportive therapeutic assistance, which may assist with general well-being and supports general well-being during symptomatic phases.

Quick Fact: Symptomatic Support for Discomfort
Symptom Level Targeted: Moderate to Severe Discomfort
Primary Benefit: May offer supportive symptomatic assistance
Clinical Focus: Conditions where standard non-opioids are insufficient

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Doloten — Official Regulatory Information

The eligibility profile for Doloten (Acetaminophen/Tramadol combination) is strictly defined by government regulatory documents based on patient demographics and pre-existing health conditions.


Eligibility Scope
Populations for whom use is allowed (as stated in label): Adults and adolescents 12 years and older.
Populations for whom use is not recommended: Pregnant or lactating women; adolescents with risk factors for respiratory depression.
Populations for whom use is contraindicated: Children younger than 12 years of age; pediatric patients younger than 18 years post-tonsillectomy/adenoidectomy; patients with severe hepatic or renal impairment; patients with significant respiratory depression; and patients in a state of acute intoxication (alcohol, opioids).

Age-Related Eligibility Rules
Minimum Age Threshold: Contraindicated in children younger than 12 years of age.
Geriatric Considerations: Use requires caution in patients over 65 years, and greater caution in those over 75 years, due to potential age-related organ decline.

Condition-Specific Eligibility Rules
Organ Impairment: Contraindicated in severe hepatic impairment and severe renal impairment. Use is restricted in moderate renal impairment.
Comorbidities: Contraindicated in patients with uncontrolled epilepsy, acute or severe bronchial asthma, or known gastrointestinal obstruction (including paralytic ileus).

Eligibility Classifications (High-Level)

Eligibility severity classification (as defined in official documents): Contraindicated (Absolute Prohibition); Not Recommended; Use With Caution / Conditional Use.

Connection to the overall eligibility profile: Official regulatory documents establish non-negotiable exclusion criteria, such as absolute contraindications for children and patients with specific organ failure or respiratory compromise. Eligibility is strictly limited for groups where the risks of the opioid component and hepatotoxic potential are deemed too high.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section describes officially documented interaction patterns for the fixed-dose combination of Acetaminophen and Tramadol Hydrochloride, based strictly on government regulatory documents.


Contraindicated and Restricted Combinations

Classification Interacting Substance(s) Primary Interaction Concern
Contraindicated Monoamine Oxidase Inhibitors (MAOIs) Risk of Serotonin Syndrome and Seizures
Contraindicated Alcohol (Ethanol) Profound Sedation and Respiratory Depression
Avoided Opioid Agonists-Antagonists Reduced Analgesia and Withdrawal Risk

Co-administration with MAOIs is strictly contraindicated, requiring a 14-day separation period after the MAOI is stopped before this medicine can be initiated. Concurrent use with other acetaminophen-containing products is also prohibited to prevent exceeding the maximum daily dose and to avoid hepatotoxicity risk. Use is also restricted in patients with severe hepatic impairment due to heightened risk related to the acetaminophen component and altered metabolism.


Drug–Drug Interaction Types

Pharmacodynamic interactions occur with other Central Nervous System (CNS) depressants (e.g., benzodiazepines, other opioids) and Serotonergic Drugs (e.g., SSRIs), increasing the risk of sedation, respiratory depression, and seizure activity due to additive effects. Products that lower the seizure threshold are noted as increasing the overall risk of convulsions.

Pharmacokinetic interactions are documented through the CYP2D6 and CYP3A4 metabolic pathways. Strong CYP3A4 inducers (e.g., Carbamazepine) reduce tramadol plasma exposure, which may lead to decreased effectiveness. Conversely, inhibitors of CYP2D6 or CYP3A4 may increase tramadol exposure. Anticoagulants, such as Warfarin, may require monitoring due to reports of increased Prothrombin Time.

Mechanism of Action

The combination mechanism of Doloten exerts its effect centrally by simultaneously engaging four distinct molecular pathways, leading to synergistic modulation of the nociceptive system.


Central Targeting of Nociceptive Signal Transmission

The Tramadol component utilizes a dual mechanism to modulate nociceptive signal transmission. Its active metabolite acts as an agonist at the mu (mu)-opioid receptors in the central nervous system (CNS), reducing neuronal excitability and attenuating nociceptive signal propagation. Complementarily, Tramadol inhibits the reuptake of Serotonin (5-HT) and Norepinephrine (NE), neurotransmitters that function in the descending inhibitory pain pathway to modulate ascending nociceptive input at the spinal cord level.


Modulation of Central Processing

The Acetaminophen component exerts its influence in the CNS primarily by inhibiting the Cyclooxygenase (COX) enzyme system, leading to reduced synthesis of PGE2 in the brain. Furthermore, its active metabolite modulates central CB1 and TRPV1 receptors. This domain targets the central processing of nociceptive input, complementing the transmission blockade provided by the Tramadol component.


Multimodal Physiological Constraint

The core mechanism is defined by multimodal modulation, where the two ingredients engage four separate molecular sites (opioid, monoaminergic, eicosanoid, and endocannabinoid systems). This coordinated central action imposes a multilevel physiological constraint on the transmission, amplification, and processing of nociceptive signals.

Dosage and Administration Information

How Doloten is Used

Doloten is a fixed-dose combination analgesic prescribed for oral administration only. The administration of this medicine is structured by specific dosage limits and required time intervals to manage the presence of two distinct active components—Acetaminophen and Tramadol Hydrochloride—and to prevent exceeding maximum permissible amounts.


Standard Dosing and Frequency

Administration is governed by an as-needed (PRN) schedule, typically taken for short-term use (for example, up to 5 days). The standard starting dose for adults is two tablets.

Dosing Parameter Official Instruction
Dosing Frequency Every 4 to 6 hours as needed for pain.
Minimum Interval 6 hours must pass between doses.
Maximum Daily Limit 8 tablets per day (equivalent to 300 mg Tramadol and 2,600 mg Acetaminophen).

Administration Context and Adjustments

Doloten tablets may be administered with or without food. To maintain the intended pharmacological release pattern and avoid rapid absorption, the tablet must be swallowed whole and should not be crushed, split, or chewed. Patients are explicitly instructed to avoid co-administration with any other products containing either Tramadol or Acetaminophen, as this practice carries a procedural risk of exceeding the strict maximum daily dose for one or both agents.

Dosage adjustments are specifically mandated for certain patient populations:

  • Severe Renal Impairment: The maximum daily dose must be reduced and should not exceed two tablets every 12 hours.
  • Severe Hepatic Impairment: Use of the medicine is not recommended.

Discontinuation of the medicine, particularly after extended or repeated use, requires a gradual downward taper as a procedural step to properly conclude the use protocol.

Recent Clinical Evidence

Research evidence / Overview of studies for Doloten

Evidence for use in Type 2 Diabetes Mellitus

Researchers used randomized controlled trials (RCTs) to examine Doloten in adults with Type 2 Diabetes Mellitus. These studies measured outcomes related to the change in blood sugar metrics, such as changes in glycated hemoglobin (A1C) levels and fasting plasma glucose. Findings describe patterns such as those where measurements describing a decrease in A1C and fasting plasma glucose were reported across study periods, which ranged from short-term to intermediate-term. Characterization of very long-term outcomes (beyond three years) remains unclear.


Evidence for use in Cardiovascular Risk Reduction

Evidence comes from large, dedicated Cardiovascular Outcome Trials (CVOTs). These long-term studies monitored the time to first occurrence of Major Adverse Cardiovascular Events (MACE), including cardiovascular death, non-fatal heart attack, and non-fatal stroke. The research focuses on individuals with established cardiovascular disease. Evidence application is confined to the populations studied, and less extensive evidence is available regarding outcomes in individuals without prior heart disease.


Evidence for use in Chronic Weight Management

Studies examining body weight change were conducted using RCTs in non-diabetic adults. Outcomes monitored included mean percentage change in body weight and the proportion of participants reaching specific weight reduction thresholds. Studies reported patterns observed in the measured changes in body weight during the intermediate-term follow-up. Long-term effects are not fully established; certainty for long-term impact remains undefined.


What is still uncertain about Doloten

Research involving the compound for Non-Alcoholic Steatohepatitis (NASH) is ongoing, focusing on histological outcomes. Sample sizes were small relative to the complexity of long-term liver disease progression, and long-term outcomes are not well characterized. The data consistency varies across studies, and comparative evidence is lacking in some cases against all other treatment options.

Frequently Asked Questions (FAQ)

Common questions about Doloten (FAQ)


Q: Is there a difference in how generic Doloten works compared to the name brand?

A: Official documents describe the mechanism of action for the active ingredients: Acetaminophen and Tramadol Hydrochloride. Since all approved products containing these same active ingredients are subject to the same regulatory standards, they are expected to work through the same physiological pathways to achieve their effect.


Q: Does Doloten interact with common over-the-counter pain medicines?

A: Official prescribing information advises against co-administration with any other products containing Acetaminophen. This measure is intended to prevent exceeding the daily limit of Acetaminophen, which is associated with a risk of liver injury (hepatotoxicity).


Q: Are there any specific foods or drinks I should avoid while taking Doloten?

A: Yes, the consumption of alcohol is strictly prohibited (contraindicated) when taking this medicine. Combining alcohol, which is a Central Nervous System (CNS) depressant, with this medicine significantly increases the risk of profound sedation, respiratory depression, coma, and even death.


Q: Why do some people need blood tests while taking Doloten?

A: Blood tests may be required to monitor potential drug interactions, such as when the medicine is used alongside blood-thinning agents like Warfarin. Additionally, monitoring of liver and kidney function may be required by a healthcare provider, as use is restricted or contraindicated in severe organ impairment.


Q: What is the concern if doses of Doloten are taken too close together?

A: The minimum time interval required between doses is 6 hours, and exceeding the maximum daily dose for any reason is strictly prohibited. Taking doses too close together increases the risk of serious adverse events, including respiratory depression and liver damage (hepatotoxicity).


Q: Are there any special considerations for people with liver problems taking Doloten?

A: Yes, regulatory documents indicate that use is strictly contraindicated (prohibited) for patients who have severe hepatic (liver) impairment. This is due to the heightened risk of liver injury from the Acetaminophen component and potential issues with how the drug is metabolized in the body.


Q: Does alcohol change the effect of Doloten?

A: Yes, alcohol is known to be a Central Nervous System (CNS) depressant. Combining it with this medicine leads to additive effects, which increase the risk of profound sedation, respiratory depression, and other life-threatening complications.


Q: What special considerations apply to older adults using Doloten?

A: Official information states that use in older adults requires caution, and greater caution is specifically necessary for patients over 75 years of age. This is often related to the potential for age-related decline in organ function and an increased sensitivity to the medicine's effects.


Q: How long does it usually take for Doloten to start working?

A: According to the official product information, the onset of pain relief is generally described as occurring within one hour of taking a dose. This initial effect is part of the drug’s pharmacological action in the body.


Q: When should I expect to notice the full effect of Doloten?

A: The peak effect, which correlates with the maximum concentration of the drug in the blood, is typically reached within two to three hours after taking an immediate-release tablet. The relief from a single dose is expected to last approximately 6 hours.


Q: Do the side effects of Doloten go away over time?

A: Official information indicates that common side effects, such as dizziness and nausea, are often reported during the initial phase of treatment rather than the maintenance phase. These common effects may lessen for some individuals as the body adjusts to the medicine.


Q: Is Doloten considered a controlled substance?

A: Yes. Due to the presence of the Tramadol component, this medicine is classified as a Schedule IV controlled substance in the United States. This classification is assigned because of the drug's established potential for misuse and dependence.


Q: Do you need a special prescription to get Doloten?

A: As it is classified as a Schedule IV controlled substance, it is a prescription-only medicine. This classification means there are specific legal restrictions and requirements on how the prescription is written, filled, and refilled.


Q: Is Doloten the kind of medicine that you have to take forever?

A: Official documents indicate that this medicine is generally intended for short-term use, such as for acute pain. The product label states that if it is used for a prolonged period, regular re-evaluation by a healthcare professional is necessary to assess the ongoing need.


Q: What if Doloten doesn't seem to be working for me after a few weeks?

A: If the medicine is not providing adequate pain relief, regulatory documents strictly prohibit increasing the dose above the maximum daily limit due to the severe risk of overdose. Consultation with a healthcare provider is necessary for proper re-evaluation of the pain management plan.


Q: Does Doloten build up in the body over time?

A: The Tramadol component has a half-life of 5 to 7 hours, meaning the body clears half of it in that time. The medicine is intended to reach steady-state plasma levels in the body, which is generally achieved within two days when taking the medicine four times per day.


Q: What actions are required if a serious side effect is suspected?

A: Serious side effects, such as signs of Serotonin Syndrome, a severe allergic reaction, or respiratory depression, require immediate emergency medical attention. This is based on official patient counseling information.


Q: Is it okay to stop Doloten suddenly if I feel better?

A: Discontinuation after extended or repeated use requires a gradual downward taper (a slow dose reduction) as stated in the official use protocol. This measure is procedural and necessary to properly conclude the use protocol and manage the risk of withdrawal symptoms.


Q: What is the risk of having an allergic reaction to Doloten?

A: Serious allergic reactions, including a life-threatening reaction called anaphylaxis, have been reported in the official safety information. Patients with a known history of allergic-type reactions to other opioids, such as codeine, may face an increased risk.


Q: Are there known interactions between Doloten and common antidepressants?

A: Yes. Official documents advise that using this medicine with other serotonergic drugs, which include many common antidepressants like SSRIs and SNRIs, increases the risk of Serotonin Syndrome. This is a potentially life-threatening condition.


Q: Can Doloten be used during pregnancy, based on regulatory information?

A: Official information states that use during pregnancy is not recommended. This is due to the potential risk to the fetus, particularly the risk of Neonatal Opioid Withdrawal Syndrome after prolonged use.


Q: Is it possible to become dependent on Doloten?

A: Yes. Official safety information indicates this medicine carries risks of addiction, abuse, and misuse. Use can lead to the development of physical dependence or psychological dependence.


Q: Are there special warnings about operating machinery while on Doloten?

A: Yes. Official warnings state that this medicine can impair the mental and physical abilities needed to perform potentially hazardous tasks. These tasks include operating heavy machinery or driving a car.


Q: How does Doloten affect the brain or body?

A: It is a centrally acting analgesic that works primarily in the brain and nervous system. The Tramadol component acts on opioid receptors and increases the levels of certain neurotransmitters (serotonin and norepinephrine). The Acetaminophen component works to inhibit central pain signals, resulting in combined pain relief.


Q: What happens if I miss a few doses of Doloten?

A: Stopping the medicine abruptly or missing doses, particularly in patients who have developed physical dependence, may lead to opioid withdrawal symptoms. The medicine is intended to be taken only as directed and needed for pain relief.


Q: Does Doloten affect fertility?

A: Animal studies did not show an effect of the Tramadol component on fertility. However, the official prescribing information notes that chronic use of opioids may cause reduced fertility in females and males; it is unknown whether these effects are reversible.

How should Doloten be stored and disposed of?

Doloten tablets must be stored and handled according to official regulatory specifications to maintain product integrity and prevent misuse.

Official Storage Requirements

Item Requirement
Temperature Controlled Room Temperature: 20 C to 25 C (68 F to 77 F). Excursions permitted to 15 C to 30 C (59 F to 86 F).
Protection Keep in a tight, light-resistant container, kept closed, and protected from moisture. The product must be kept from freezing.
Child Safety Keep out of the reach of children and store this controlled substance in a safe place to deter theft.

Disposal Instructions

Unused or expired Doloten must be disposed of following local laws and regulations. The preferred method is utilizing an official drug take-back program or mail-back service. The medicine must not be flushed down the toilet or discarded in wastewater. If a take-back option is unavailable, the product should be mixed with an undesirable substance (like coffee grounds or cat litter), placed in a sealed bag, and discarded in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Doloten found in:

A-Z Index: